logo
Plus   Neg
Share
Email

East West Bancorp Q1 Profit Rises; Lifts FY12 EPS View - Quick Facts

East West Bancorp Inc. (EWBC) reported first-quarter net income available to common stockholders of $66.37 million or $0.45 per share, up from $54.36 million or $0.37 per share in the same quarter of last year. Analysts polled by Thomson Reuters expected the company to report earnings of $0.43 per share for the quarter. Analysts' estimates typically exclude special items.

Earnings per share for the first quarter of 2012 was 22% higher than the prior year. This increase in earnings is reflective of healthy, profitable and prudent growth in our loan and deposit portfolios, which has resulted in a strong net interest margin of 4.21% and a reduced cost of deposits down to 0.47%.

Net interest income for the quarter rose to $218.92 million from $208.83 million in the prior year quarter. Non-interest income was $21.74 million, up from $11.04 million in year ago quarter.

The company expects earnings per share for the second quarter of 2012 to be in the range of $0.43 to $0.45 per share. Analysts expect the company to report earnings of $0.45 per share for the second-quarter.

The company currently estimates that earnings per share for the full year of 2012 will range from $1.78 to $1.82, or an increase of 11% to 14% from 2011. Also, this updated guidance for the full year 2012 is an increase of $0.04 per share from its previous guidance. Analysts expect the company to report earnings of $1.83 per share for fiscal 2012.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
In the age of social media, it takes mere hours for a company to suffer the backlash of of allegations of racism. For some companies, these incidents have hurt their bottom line and sullied their reputations. For others, they were a blip caused by clumsy if not altogether coincidental missteps. In... BJ's Wholesale Club Holdings Inc., which is planning a return to the public market, has set terms for its planned initial public offering or IPO. In a filing with the U.S. Securities and Exchange Commission, the warehouse club operator said Monday that it plans to offer 37.5 million shares priced between $15 and $17 per share. At the top end of the range, the offering would raise $637.5 million. Shares of Valeant Pharmaceuticals International Inc. are falling more than 6 percent in Monday's trading following news that the U.S. Food and Drug Administration has failed to approve the Canada-based company's Duobrii lotion for the treatment of plaque psoriasis. Ortho Dermatologics, a division of Valeant Pharmaceuticals, said it has received a Complete Response Letter or CRL from the FDA.
Follow RTT